184 related articles for article (PubMed ID: 3538736)
21. Insulin deficiency and insulin resistance in type 2 (non-insulin-dependent) diabetes: quantitative contributions of pancreatic and peripheral responses to glucose homeostasis.
Nesher R; Della Casa L; Litvin Y; Sinai J; Del Rio G; Pevsner B; Wax Y; Cerasi E
Eur J Clin Invest; 1987 Jun; 17(3):266-74. PubMed ID: 3113971
[TBL] [Abstract][Full Text] [Related]
22. Insulin secretion, insulin sensitivity, and hepatic insulin extraction in first-degree relatives of type 2 diabetic patients.
Pimenta WP; Santos ML; Cruz NS; Aragon FF; Padovani CR; Gerich JE
Braz J Med Biol Res; 2003 Mar; 36(3):301-8. PubMed ID: 12640493
[TBL] [Abstract][Full Text] [Related]
23. Secretion and hepatic extraction of insulin after weight loss in obese noninsulin-dependent diabetes mellitus.
Henry RR; Brechtel G; Griver K
J Clin Endocrinol Metab; 1988 May; 66(5):979-86. PubMed ID: 3283164
[TBL] [Abstract][Full Text] [Related]
24. Characterization of alterations in glucose and insulin metabolism in Prader-Willi subjects.
Schuster DP; Osei K; Zipf WB
Metabolism; 1996 Dec; 45(12):1514-20. PubMed ID: 8969285
[TBL] [Abstract][Full Text] [Related]
25. Impaired insulin action in the liver, but not in adipose tissue or muscle, is a distinct metabolic feature of impaired fasting glucose in obese humans.
Ter Horst KW; Gilijamse PW; Ackermans MT; Soeters MR; Nieuwdorp M; Romijn JA; Serlie MJ
Metabolism; 2016 May; 65(5):757-763. PubMed ID: 27085782
[TBL] [Abstract][Full Text] [Related]
26. Body fat mass distribution. Influence on metabolic and atherosclerotic parameters in non-insulin dependent diabetics and obese subjects with and without impaired glucose tolerance. Influence of weight reduction.
Van Gaal L
Verh K Acad Geneeskd Belg; 1989; 51(1):47-80. PubMed ID: 2800685
[TBL] [Abstract][Full Text] [Related]
27. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.
Gastaldelli A; Cusi K; Pettiti M; Hardies J; Miyazaki Y; Berria R; Buzzigoli E; Sironi AM; Cersosimo E; Ferrannini E; Defronzo RA
Gastroenterology; 2007 Aug; 133(2):496-506. PubMed ID: 17681171
[TBL] [Abstract][Full Text] [Related]
28. Quantitative study of insulin secretion and clearance in normal and obese subjects.
Polonsky KS; Given BD; Hirsch L; Shapiro ET; Tillil H; Beebe C; Galloway JA; Frank BH; Karrison T; Van Cauter E
J Clin Invest; 1988 Feb; 81(2):435-41. PubMed ID: 3276729
[TBL] [Abstract][Full Text] [Related]
29. Acute effects of valsartan on insulin sensitivity in obese, non-hypertensive subjects with and without type 2 diabetes.
Luzio SD; Dunseath G; Owens DR
Horm Metab Res; 2002 May; 34(5):271-4. PubMed ID: 12063642
[TBL] [Abstract][Full Text] [Related]
30. Insulin resistance and decreased insulin response to glucose in lean type 2 diabetics.
Wajngot A; Roovete A; Vranić M; Luft R; Efendić S
Proc Natl Acad Sci U S A; 1982 Jul; 79(14):4432-6. PubMed ID: 6750603
[TBL] [Abstract][Full Text] [Related]
31. Control of insulin secretion during fasting hyperglycemia in adult diabetics and in nondiabetic subjects during infusion of glucose.
Goodner CJ; Conway MJ; Werbach JH
J Clin Invest; 1969 Oct; 48(10):1878-87. PubMed ID: 5822593
[TBL] [Abstract][Full Text] [Related]
32. Glucose tolerance, insulin secretion, and insulin sensitivity in nonobese and obese Japanese subjects.
Matsumoto K; Miyake S; Yano M; Ueki Y; Yamaguchi Y; Akazawa S; Tominaga Y
Diabetes Care; 1997 Oct; 20(10):1562-8. PubMed ID: 9314636
[TBL] [Abstract][Full Text] [Related]
33. Gluconeogenesis in moderately and severely hyperglycemic patients with type 2 diabetes mellitus.
Boden G; Chen X; Stein TP
Am J Physiol Endocrinol Metab; 2001 Jan; 280(1):E23-30. PubMed ID: 11120655
[TBL] [Abstract][Full Text] [Related]
34. Modified glucagon test allowing simultaneous estimation of insulin secretion and insulin sensitivity: application to obesity, insulin-dependent diabetes mellitus, and noninsulin-dependent diabetes mellitus.
Castillo MJ; Scheen AJ; Lefebvre PJ
J Clin Endocrinol Metab; 1995 Feb; 80(2):393-9. PubMed ID: 7852495
[TBL] [Abstract][Full Text] [Related]
35. Peripheral tissue glucose uptake is not reduced after an oral glucose load in Southern Italian subjects at risk of developing non-insulin-dependent diabetes mellitus.
Thorburn AW; Proietto J
Metabolism; 1999 Jan; 48(1):80-5. PubMed ID: 9920149
[TBL] [Abstract][Full Text] [Related]
36. Effects of methyltestosterone on insulin secretion and sensitivity in women.
Diamond MP; Grainger D; Diamond MC; Sherwin RS; Defronzo RA
J Clin Endocrinol Metab; 1998 Dec; 83(12):4420-5. PubMed ID: 9851788
[TBL] [Abstract][Full Text] [Related]
37. Pathogenesis of glucose intolerance and diabetes mellitus in cirrhosis.
Petrides AS; Vogt C; Schulze-Berge D; Matthews D; Strohmeyer G
Hepatology; 1994 Mar; 19(3):616-27. PubMed ID: 8119686
[TBL] [Abstract][Full Text] [Related]
38. Hepatic and peripheral insulin resistance following streptozotocin-induced insulin deficiency in the dog.
Bevilacqua S; Barrett EJ; Smith D; Simonson DC; Olsson M; Bratusch-Marrain P; Ferrannini E; DeFronzo RA
Metabolism; 1985 Sep; 34(9):817-25. PubMed ID: 3897768
[TBL] [Abstract][Full Text] [Related]
39. Hyperglycaemic clamp and insulin binding to isolated monocytes before and after glibenclamide treatment of mild type II diabetics.
Pagano G; Lombardi A; Pisu E; Bozzo C; Masciola P; Ferraris GM; Bruno A
Horm Metab Res; 1984 May; 16(5):215-20. PubMed ID: 6429023
[TBL] [Abstract][Full Text] [Related]
40. Abnormalities of islet B-cell function, insulin action, and fat distribution in women with histories of gestational diabetes: relationship to obesity.
Ward WK; Johnston CL; Beard JC; Benedetti TJ; Porte D
J Clin Endocrinol Metab; 1985 Dec; 61(6):1039-45. PubMed ID: 3902865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
